OR WAIT null SECS
February 11, 2016
Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.
December 03, 2015
Seqirus, CSL Limited’s influenza vaccine business, announced the opening of their corporate headquarters in the United Kingdom.
November 05, 2015
South Africa’s Biovac Institute, which develops and produces vaccines for the country, launched a public-private partnership with Pfizer to enable local manufacturing of Prevenar 13, a vaccine against pneumonia-causing bacteria.
October 27, 2015
According to a third-quarter earnings report, Pfizer’s vaccine business contributed nearly 14% to its total revenue.
October 23, 2015
Univercells will integrate its single-use bioprocess with the Takeda vaccines production platform to allow local production.
August 13, 2015
CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.
July 24, 2015
EMA gives GSK’s malaria candidate vaccine a positive opinion for the prevention of malaria in young children in sub-Saharan Africa.
July 16, 2015
GSK accelerates delivery timeline for US quadrivalent flu vaccine.
July 13, 2015
The European Medicines Agency reviews the safety of human papillomavirus vaccines.
July 07, 2015
A study now underway on vaccine manufacturing examines the effects of focusing on consistency during manufacturing, instead of post-production testing.